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INTRODUCTION
Pheochromocytoma usually presents with typical signs
and symptoms, such as headache, sweating, and palpita-
tions due to excessive catecholamine release. Few publica-
tions have reported that these tumors are capable of
secreting a variety of bioactive neuropeptides and hormones
other than catecholamines, resulting in unusual clinical
manifestations.
1-4 Interleukin-6 (IL-6) is a multifunctional
molecule that plays an important role in hematopoiesis and
immune and inflammatory responses. IL-6 stimulates the
activation and differentiation of B and T lymphocytes,
induces fever and regulates the acute-phase protein synth-
esis of proteins such as C-reactive protein (CRP) and
fibrinogen.
5 IL-6 is mainly produced by lymphocytes and
monocytes but can also be produced by other cell types
including fibroblasts, keratinocytes, mesangial cells,
endothelial cells, and adrenal cortical cells.
6,7 We report an
18-year-old normotensive, female patient who had an
interleukin-6-producing pheochromocytoma and presented
with fever of unknown origin associated with elevated
levels of inflammatory markers.
CASE REPORT
An 18-year-old girl sought medical help for her ongoing
malaise and fever following an upper respiratory tract
infection. She had experienced weight loss of 3 kg, but did
not have typical paroxysmal symptoms. Her physical
examination showed no pathological findings except a
temperature of 38.7˚C. Her blood pressure was measured
to be 90/60 mmHg. Laboratory data revealed both an
elevated erythrocyte sedimentation rate (130 mm/h) and
an elevated C-reactive protein level (98 mg/dl, normal; 0–
5). Specific and nonspecific blood and urine cultures were
negative for microbiological pathogens. Viral serological
markers were negative as well. The total blood count
revealed hypochromic and microcytic anemia (Hb: 8.6 g/dl,
Hct: %25, MCV: 75 fl, RDW: 18.9%, MCHC: 33.3 g/dl) with
marked thrombocytosis (PLT: 901000/ml) and slight neu-
trophilic leukocytosis (WBC: 12600/ml, neutrophils: 9700/
ml), which was confirmed later with both peripheral blood
and bone marrow smears. Her liver enzymes were within
the normal range.
A fever between 37.5˚C and 41˚C persisted. Contrast-
enhanced magnetic resonance imaging of the upper abdo-
men indicated a smooth-contoured right adrenal mass with
a diameter of 5.5 cm, which was hypointense and hetero-
geneous on T1-weighted images, whereas it was hyper-
intense and heterogeneous on T2-weighted images, with
nodular contrast enhancement toward the center of the mass
(Figure 1). This patient was referred to our department for
further evaluation. The morning fasting serum cortisol level,
the plasma aldosterone level and the renin activity of the
patient in the prone and upright positions were within the
normal ranges. The urinary normetanephrine level was
elevated to a level of 3612 mg/24 hours (normal; 105–354).
These findings supported the diagnosis of pheochromocy-
toma. Almost immediate cessation of the fever and a
gradual normalization of the clinical inflammatory marker
levels were achieved after four weeks of adrenergic
blockade with doxazosin. At admission, the serum inter-
leukin-6 level was measured to be 12.5 pg/mL (normal
,3.0 pg/mL), which then became 9.9 pg/mL in the second
month of the adrenergic blockade. The IL-6 level decreased
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Figure 1 - Hyperintense and heterogeneous right adrenal mass
(arrow) on a T2-weighted MRI image.
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1843to 6.6 pg/mL after complete resection of the tumor, which
proved histopathologically to be a pheochromocytoma. The
serum interleukin-6 level returned to normal a few weeks
after the operation (Figure 2).
DISCUSSION
The unusual presentation of our pheochromocytoma
case, with normal blood pressure, fever, and a marked
inflammatory response, indicates the complexity of the
clinical manifestations of this rare tumor. There have been
other reports of adrenal tumors presenting with fever,
hypertension, anemia, thrombocytosis, megakaryocytosis,
and hyperfibrinogenemia associated with elevated levels of
IL-6.
1,4,8-11 Cytokine production by the tumor could
occasionally play a crucial role in the emergence of unusual
symptoms such as fever and weight loss. IL-6 is clearly
associated with the inflammatory response mediated by the
differentiation of B-lymphocytes into immunoglobulin-
producing plasmacytes and potently stimulates the pro-
duction of acute inflammatory proteins while decreasing
serum albumin levels.
8,9 IL-6 is also the cause of mega-
karyocytosis.
12,13 IL-6 over-production can be either
ascribed directly to the tumor or indirectly accounted for
by tumoral production as a consequence of the high levels
of circulating norepinephrine. The relief of symptoms and
the normalization of the inflammatory marker levels
following the decrease in the level of IL-6 after resection
of the tumor strongly support the role of IL- 6 in this
unusual presentation of our case. Although there are some
data demonstrating the effectiveness of non-steroidal anti-
inflammatory drugs in reducing IL-6 levels and inflamma-
tory symptoms in patients with pheochromocytomas,
1,4,12
our patient achieved fever remission through the use of
alpha-adrenergic receptor blockers, corroborating the
results of a previous study.
14 Our patient had no
hypertension despite high catecholamine levels. This
situation could be explained by the increased nitric oxide
synthesis due to IL–6 activity, which might have led to
vasodilation.
15,16
CONCLUSION
Pheochromocytoma may be a cause of paraneoplastic
syndrome with pyrexia in addition to inducing a marked
increase in the levels of inflammatory markers. IL-6 appears
to be the primary mediator. This rare tumor has to be
considered in the vast differential diagnosis of fever of
unknown origin.
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